Drug Repositioning for COVID-19
Article Sidebar
Main Article Content
Drug repositioning is a strategy that identifies new uses of approved drugs, to treat conditions different from their original purpose. With the advance of COVID-19 and the declaration of a pandemic; It has become the closest alternative to slow the advance of the virus. Antimalarial, antiviral drugs, antibiotics, glucocorticoids, monoclonal antibodies, among others, are being studied; his findings, although preliminary, could establish a starting point in the search for a solution.
In this article, we present a selection of drugs, of different classes and with potential activity to combat COVID-19, whose trials are ongoing; and as proofs of concept, double blind, event-driven add-on, would allow proposing research that generates results in less time and preserving the quality criteria for drug development and approval by regulatory agencies.
- COVID-19
- drug repositioning
- pandemic
- therapeutic alternatives
Vicente Benavides-Cordoba, Universidad del Valle. Cali, Colombia
Education:
Physiotherapist / Universidad del Cauca
Specialist in Cardiopulmonary Physical Therapy / Universidad del Valle
PhD (c) in Biomedical Sciences / Universidad del Valle
Clinical Training Fellowship / European Respiratory Society - Amsterdam Medical Center
Research Area
Pulmonary Rehabilitation, Pulmonary Hypertension, Drug Repositioning.
https://orcid.org/0000-0002-9129-0183
Recent Articles
Benavides-Cordoba, V., Silva-Medina, M., Varela, M. X., & Palacios, M. (2020). Subchronic
toxicity of the pulmonary hypertension model due to low-dose monocrotaline in rats. Journal of
Pharmacy & Pharmacognosy Research, 8(4), 308-315.
Benavides-Cordoba, V., Aviles, S., Ascuntar, C., Orozco, L., Mosquera, R., & Rivera, J. (2020).
Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in
COPD patients. Pulmonary Pharmacology & Therapeutics, 61, 101898.
Benavides-Cordoba, V., Weil, M. S. M., Castaño, S., & Palacios, M. (2019). Hemodynamical
effects of metformin and sildenafil in the treatment of experimental pulmonary hypertension.
European Respiratory Journal. 54: PA4752
Betancourt-Peña J., Ávila Valencia, J. C., Assis, J. K., Gutiérrez, H. H., & Benavides-Cordoba,
V. (2019). Benefits of Pulmonary Rehabilitation in Patients with COPD with Use and without the
Use of Supplemental Oxygen During Exercise. Current Respiratory Medicine Reviews, 15(4),
281-288.
Ávila-Valencia, J. C., Hurtado-Gutiérrez, H., Benavides-Córdoba, V., & Betancourt-Pena, J.
(2019). Aerobic exercise in patients with heart failure with and without ventricular dysfunction in
a cardiac rehabilitation programme. Revista Colombiana de Cardiología, 26(3), 162-168.
Betancourt-Peña, J., Benavides-Córdoba, V., Avila-Valencia, J. C., & Rosero-Carvajal, H. E.
(2019). Differences Between COPD Patients of a Pulmonary
Downloads
- Vicente Benavides-Cordoba, Martijn A. Spruit, Muscle training in patients with pulmonary hypertension. a narrative review , Colombia Medica: Vol. 52 No. 4 (2021)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use